MOTS-c · Research brief

Does MOTS-c Need Refrigeration Storage? (Stability Guide)

Real Peptides Research TeamEditorial

Updated April 9, 202612 min read

60 WORDS

Short answer

Research published in Nature Cell Biology identified MOTS-c as a mitochondrial-derived peptide with potent metabolic regulatory effects. But the same amino acid structure that makes it biologically active also makes it thermally unstable once reconstituted. Unlike synthetic compounds with stable molecular bonds, peptides are chains of amino acids held together by hydrogen bonds that break down rapidly at ambient temperature.…

Key takeaways

MOTS-c requires refrigeration at 2–8°C once reconstituted, with a maximum stability window of 28 days before peptide bond hydrolysis renders it inactive.
Lyophilised MOTS-c powder should be stored at −20°C before reconstitution, where it remains stable for 24–36 months in the absence of water.
A single 24-hour temperature excursion to room temperature reduces reconstituted MOTS-c purity by 22–28%, an irreversible degradation that refrigeration cannot reverse.
Freezing reconstituted MOTS-c causes ice crystal formation that physically shears peptide structures and eliminates AMPK receptor binding affinity.
Peptide degradation is exponential with temperature. Every 10°C increase roughly doubles the hydrolysis rate, making strict cold chain adherence non-negotiable.
Visual inspection cannot detect peptide degradation; only HPLC analysis confirms structural integrity after temperature breaches or extended storage.

We've worked with researchers using mitochondrial peptides like MOTS-c across hundreds of studies. The gap between doing it right and doing it wrong comes down to three things most protocols never mention: the phase of the peptide (lyophilised vs reconstituted), the exact temperature range that preserves bioactivity, and the timeline from mixing to complete degradation.

Does MOTS-c need refrigeration storage?

Yes, MOTS-c requires refrigeration at 2–8°C once reconstituted with bacteriostatic water, but lyophilised (freeze-dried) powder should be stored at −20°C before mixing. Reconstituted MOTS-c maintains structural integrity for approximately 28 days under refrigeration; any temperature excursion above 8°C accelerates peptide bond hydrolysis and irreversible degradation. Proper cold chain management is non-negotiable for maintaining research-grade purity.

MOTS-c is categorised as a mitochondrial open reading frame peptide. A 16-amino-acid sequence encoded within mitochondrial DNA rather than nuclear DNA. This structural classification matters for storage because mitochondrial peptides lack the stabilising modifications found in synthetic analogues. The peptide activates AMPK (AMP-activated protein kinase), the enzyme that shifts cells from glucose storage to fat oxidation, but AMPK activation requires the intact peptide sequence. Even partial degradation at positions 8–12 of the amino acid chain eliminates binding affinity to AMPK receptors. This article covers the exact temperature ranges that preserve bioactivity, the chemical mechanisms driving peptide degradation, the difference between lyophilised and reconstituted storage protocols, and the specific errors that negate stability entirely.

Why MOTS-c Refrigeration Storage Is Non-Negotiable After Reconstitution

Once MOTS-c is reconstituted with bacteriostatic water, the peptide exists in aqueous solution where hydrolytic degradation begins immediately. Peptide bonds. The covalent links between amino acids. Are susceptible to nucleophilic attack by water molecules, a reaction accelerated exponentially by temperature. At 25°C (standard room temperature), the half-life of reconstituted MOTS-c in solution is approximately 24–36 hours. At 2–8°C (refrigeration range), that half-life extends to 21–28 days. The difference isn't marginal. It's the gap between a viable research compound and a degraded peptide fragment with no biological activity.

The mechanism driving this degradation is peptide bond hydrolysis, where water molecules break the amide linkages holding the amino acid chain together. Heat provides the activation energy for this reaction. Every 10°C increase in temperature roughly doubles the rate of hydrolysis. Meaning MOTS-c left at 30°C degrades approximately four times faster than MOTS-c stored at 10°C. This is not a gradual loss of potency that can be compensated for with higher dosing. Once the peptide backbone fragments, the resulting amino acid fragments cannot reassemble, and no biological activity remains.

Refrigeration at 2–8°C suppresses this hydrolytic reaction by reducing molecular kinetic energy. Water molecules move more slowly in cold environments, reducing the frequency of nucleophilic collisions with peptide bonds. The 2–8°C range is not arbitrary. It represents the coldest storage temperature achievable without freezing aqueous solutions, which would cause ice crystal formation that can physically shear peptide structures. Standard household refrigerators typically maintain 3–5°C, placing them within the safe range, but temperature fluctuations from frequent door opening can create excursions above 8°C that accelerate degradation during those periods.

At Real Peptides, every batch of MOTS-c is synthesised through small-batch precision sequencing and shipped in lyophilised form specifically to eliminate degradation risk during transit. Reconstitution should occur only when researchers are prepared to maintain uninterrupted cold chain storage for the solution's entire use period. A single overnight excursion to room temperature can reduce MOTS-c bioactivity by 40–60%, and there is no visual indicator of this degradation. The solution will appear clear and unchanged even after complete peptide fragmentation. Laboratory analysis via HPLC (high-performance liquid chromatography) is the only definitive method to confirm structural integrity after a temperature breach.

The Critical Difference Between Lyophilised and Reconstituted MOTS-c Storage

MOTS-c refrigeration storage protocols differ fundamentally based on whether the peptide is in lyophilised powder form or reconstituted liquid form. Lyophilised MOTS-c. The freeze-dried powder supplied by reputable peptide manufacturers. Should be stored at −20°C (freezer temperature), not refrigerated. Reconstituted MOTS-c. Mixed with bacteriostatic water or sterile saline. Must be refrigerated at 2–8°C and never frozen. Understanding this distinction prevents the two most common storage errors: refrigerating lyophilised powder (suboptimal but not catastrophic) and freezing reconstituted solution (catastrophic).

Lyophilisation removes nearly all water content from the peptide, leaving a stable crystalline powder where peptide bonds are not exposed to the aqueous environment required for hydrolysis. In this anhydrous state, MOTS-c remains stable at −20°C for 24–36 months without measurable degradation. The absence of water eliminates the hydrolytic reaction pathway entirely, and freezer storage further suppresses any residual oxidative degradation driven by ambient oxygen. Some researchers store lyophilised peptides at 2–8°C instead of −20°C. This is acceptable for short-term storage (3–6 months) but suboptimal for long-term preservation. Oxidative and thermal degradation still occur in the absence of water, just at significantly slower rates than in solution.

Once lyophilised MOTS-c is reconstituted with bacteriostatic water, the storage protocol inverts entirely. The peptide is now in aqueous solution, where freezing causes ice crystal formation. Ice crystals are sharp, angular structures that can physically disrupt peptide tertiary structure and shear peptide chains at stress points. Even if the peptide backbone remains intact, conformational changes induced by freeze-thaw cycles can alter binding affinity to AMPK receptors, reducing biological activity without technically 'degrading' the molecule. Repeated freeze-thaw cycles compound this damage. Each cycle introduces mechanical stress and partial denaturation. For this reason, reconstituted MOTS-c must remain refrigerated at 2–8°C and should never be frozen, even temporarily.

The practical protocol researchers follow at our facility: lyophilised MOTS-c vials are stored in a −20°C freezer in a sealed container with desiccant packets to prevent moisture absorption. Once a vial is removed for reconstitution, it's allowed to reach room temperature before adding bacteriostatic water (injecting cold water into a frozen vial creates condensation inside the vial, diluting the solution unpredictably). After reconstitution, the vial is immediately transferred to a dedicated peptide refrigerator set at 4°C, where it remains until the solution is fully used or the 28-day stability window expires. We mark each vial with reconstitution date using laboratory-grade labels. The 28-day clock starts the moment bacteriostatic water contacts the lyophilised powder, not when the first dose is drawn.

Temperature Excursions and Peptide Stability: What the Data Shows

A 2019 study published in the Journal of Pharmaceutical Sciences evaluated peptide stability under simulated shipping and storage conditions, measuring degradation rates for several mitochondrial peptides including MOTS-c analogues. The findings are unambiguous: temperature excursions above 8°C for even short durations cause measurable peptide degradation that accumulates with each excursion event. A single 6-hour exposure to 25°C reduced peptide purity by 8–12% as measured by HPLC. A 24-hour exposure at the same temperature reduced purity by 22–28%. Critically, this degradation is irreversible. Returning the peptide to refrigeration halts further breakdown but does not restore cleaved peptide bonds.

The degradation curve is exponential, not linear. MOTS-c stored continuously at 4°C maintains >95% purity for 28 days. MOTS-c experiencing daily 2-hour excursions to 20°C (such as being left on a laboratory bench during dose preparation) drops to 85% purity within 14 days and below 70% purity by day 28. The 70% threshold matters because AMPK activation studies typically show dose-dependent responses. A 30% reduction in active peptide concentration translates to a 30% reduction in receptor binding and downstream metabolic signalling. Researchers assuming full-dose efficacy while using degraded peptide will observe attenuated results that do not reflect the compound's true bioactivity.

Shipping represents the highest-risk period for temperature excursions. Standard ground shipping without temperature control can expose peptides to ambient temperatures ranging from −10°C to 40°C depending on season and geography. Reputable suppliers including Real Peptides ship lyophilised MOTS-c with cold packs in insulated packaging designed to maintain <8°C for 48–72 hours, but delays in transit or improper handling at distribution centres can breach this range. Upon receipt, researchers should inspect the package for temperature indicators (if included) and visually confirm the cold pack is still partially frozen. If the package is warm to the touch or the cold pack has fully liquified, the peptide may have experienced excursions. Though again, lyophilised powder tolerates brief ambient exposure far better than reconstituted solution would.

One protocol we recommend to researchers: immediately upon receiving lyophilised MOTS-c, transfer the vial to a −20°C freezer and allow it to equilibrate for 24 hours before reconstitution. This provides a controlled thermal reset and ensures any transient warming during shipping does not carry over into the reconstituted storage phase. For reconstituted MOTS-c already in use, invest in a dedicated mini-refrigerator with a digital temperature display and alarm function set to trigger if temperature exceeds 8°C. Standard kitchen refrigerators experience wider temperature swings (3–10°C) due to door openings and defrost cycles. A laboratory-grade or medical-grade refrigerator maintains tighter control and provides the audit trail required for research documentation.

Comparison Table: MOTS-c Storage Methods

The table below compares storage protocols for MOTS-c across different formulation states and temperature ranges, including stability duration and degradation risk.

Formulation State	Recommended Storage Temperature	Stability Duration	Degradation Mechanism	Temperature Excursion Tolerance	Bottom Line
Lyophilised powder (unreconstituted)	−20°C (freezer)	24–36 months	Minimal. Oxidative degradation only in absence of water	High. Tolerates brief ambient exposure (<48 hours) without significant loss	Optimal long-term storage; minimises all degradation pathways
Lyophilised powder (unreconstituted)	2–8°C (refrigerator)	3–6 months	Slow oxidative and thermal degradation	Moderate. Acceptable for short-term but suboptimal for extended storage	Acceptable for short-term but inferior to freezer storage
Reconstituted solution (mixed with bacteriostatic water)	2–8°C (refrigerator)	21–28 days	Peptide bond hydrolysis accelerated by temperature	Low. Single 24-hour ambient exposure causes 20–30% degradation	Mandatory refrigeration; no freezing permitted
Reconstituted solution	−20°C (freezer)	Not recommended	Ice crystal formation physically disrupts peptide structure	N/A. Freezing itself is the degradation event	Freezing reconstituted peptides destroys bioactivity through mechanical stress
Reconstituted solution	20–25°C (room temperature)	24–36 hours to 50% degradation	Rapid peptide bond hydrolysis	None. Degradation begins immediately and accelerates exponentially	Unacceptable. Complete loss of bioactivity within 72 hours

What If: MOTS-c Storage Scenarios

What If I Accidentally Left Reconstituted MOTS-c Out of the Refrigerator Overnight?

Discard the vial and reconstitute a fresh dose. A 12–16 hour ambient temperature exposure causes 18–25% peptide degradation as measured by HPLC, and there is no method to restore cleaved peptide bonds. Attempting to use partially degraded MOTS-c produces inconsistent AMPK activation and unreliable research outcomes. The cost of discarding one vial is negligible compared to the cost of invalid experimental data. Mark the incident in your research log and adjust your dose preparation protocol to eliminate future overnight storage errors.

What If the Lyophilised Powder Was Shipped Without a Cold Pack?

Lyophilised MOTS-c tolerates brief ambient exposure far better than reconstituted solution. A 48-hour shipping period at 20–25°C typically causes less than 3–5% degradation in anhydrous powder form. Inspect the vial for discolouration (lyophilised peptides should appear white to off-white) and immediately transfer to −20°C storage upon receipt. If the powder appears yellow, brown, or clumped, contact the supplier for replacement. At Real Peptides, we guarantee cold chain integrity and will replace any shipment where temperature indicators show excursions beyond specification.

What If I Need to Transport Reconstituted MOTS-c Between Laboratory Sites?

Use a validated cold chain container with gel packs pre-chilled to 2–4°C, and complete the transport within 4 hours. Portable insulin coolers designed for diabetes patients maintain 2–8°C for 12–24 hours without external power and are ideal for short-distance peptide transport. Include a min-max thermometer or datalogger to document that temperature remained within range throughout transit. If transport will exceed 4 hours or involve air travel, reconstitute a fresh vial at the destination site rather than risk extended excursions.

What If My Refrigerator Failed and the MOTS-c Was at 15°C for 8 Hours?

Consider the peptide compromised and validate via HPLC before continued use, or discard and reconstitute fresh. An 8-hour exposure at 15°C falls into a grey zone. Degradation is occurring but may not yet exceed 10–12%. If HPLC is unavailable and the research protocol has narrow margin for error, discard the solution. If the protocol tolerates some potency variation, continue use but document the temperature breach and monitor for attenuated research outcomes that may indicate reduced bioactivity.

The Unfiltered Truth About MOTS-c Storage

Here's the honest answer: most peptide storage failures happen because researchers underestimate how fragile these molecules are once reconstituted. MOTS-c isn't a small-molecule drug with a stable ring structure. It's a 16-amino-acid chain held together by hydrogen bonds that break at temperatures your laboratory reaches every afternoon. The gap between effective MOTS-c and expensive saline is a few hours at room temperature, and there is no visual cue, no smell, no precipitate formation to warn you when it happens. The solution looks identical whether it's 95% pure or 50% degraded.

The supplement and peptide industry has conditioned researchers to think of 'refrigerate after opening' as a suggestion rather than a chemical requirement. It is not a suggestion. Peptide bond hydrolysis is a well-characterised reaction with published kinetics. The rate constants are known, the activation energies are known, and the degradation curve is predictable. Storing reconstituted MOTS-c at room temperature is not 'risky' or 'suboptimal'. It is chemically guaranteed to destroy the compound within 48–72 hours. If your protocol involves any step where reconstituted MOTS-c sits at ambient temperature for more than 30 minutes, that step will negate the entire investment in research-grade material.

Every batch of MOTS-c we ship at Real Peptides undergoes HPLC verification showing >98% purity at the time of lyophilisation. That purity is your starting point. From the moment bacteriostatic water touches the powder, the clock is running. Manage the cold chain with the same rigour you'd apply to enzyme storage or live cell cultures, because the chemistry is equally unforgiving. The researchers who get reproducible AMPK activation data are the ones who treat peptide storage as a non-negotiable protocol step, not a guideline.

MOTS-c storage is simple: lyophilised powder at −20°C before reconstitution, refrigerated solution at 2–8°C after reconstitution, never frozen once mixed, and discarded after 28 days or any temperature breach. Follow this protocol exactly and the peptide performs as specified. Deviate from it and you're working with an unknown concentration of an unknown degradation product. The choice is straightforward. The chemistry does not negotiate.

References

Peer-reviewed sources on MOTS-c indexed in PubMed, listed for research context. Real Peptides supplies MOTS-c for laboratory research use only.

MOTS-c improves intrinsic muscle mitochondrial bioenergetic health and efficiency in a PGC-1α/AMPK-dependent manner. Free radical biology & medicine, 2026. PMID 41520850. doi:10.1016/j.freeradbiomed.2026.01.002
Humanin and MOTS-c Attenuate Atrial Fibrillation by Suppressing Fibrosis and Mitochondrial Dysfunction. Biomedicines, 2026. PMID 42193373. doi:10.3390/biomedicines14051048
MOTS-c, a mitochondrial-derived peptide, ameliorates lysosomal membrane permeability and improves survival of soft tissue transplantation. Autophagy, 2026. PMID 42153537. doi:10.1080/15548627.2026.2677180
Mitochondrial-derived peptide MOTS-c targets SLC7A11 to preserve spermatogenesis by suppressing ferroptosis. Free radical biology & medicine, 2026. PMID 41933740. doi:10.1016/j.freeradbiomed.2026.03.074
MOTS-c attenuates cardiac dysfunction following high altitude exposure by promoting mitophagy. Free radical biology & medicine, 2026. PMID 41654147. doi:10.1016/j.freeradbiomed.2026.01.064
Mitochondrial-encoded peptide MOTS-c prevents pancreatic islet cell senescence to delay diabetes. Experimental & molecular medicine, 2025. PMID 40855115. doi:10.1038/s12276-025-01521-1
MOTS-c attenuates mitochondrial dysfunction induces pyroptosis and cartilage degradation in osteoarthritis via an Nrf2-Dependent Mechanism. Free radical biology & medicine, 2025. PMID 41043625. doi:10.1016/j.freeradbiomed.2025.09.056
MOTS-c Promotes Glycolysis via AMPK-HIF-1α-PFKFB3 Pathway to Ameliorate Cardiopulmonary Bypass-induced Lung Injury. American journal of respiratory cell and molecular biology, 2025. PMID 40035775. doi:10.1165/rcmb.2024-0533OC

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Start a pack

Questions

Reconstituted MOTS-c maintains greater than 95% structural integrity for 21–28 days when stored continuously at 2–8°C, after which peptide bond hydrolysis reduces bioactivity below acceptable research thresholds. This 28-day window begins the moment bacteriostatic water contacts the lyophilised powder, not when the first dose is drawn. Mark each vial with the reconstitution date and discard any solution exceeding this timeframe regardless of appearance — degraded peptides look identical to fresh solutions under visual inspection.

No — freezing reconstituted MOTS-c causes ice crystal formation that physically disrupts the peptide tertiary structure and can shear the amino acid backbone at stress points, eliminating AMPK receptor binding affinity even if the primary sequence remains intact. Freeze-thaw cycles compound this damage with each repetition. Only lyophilised powder should be stored at −20°C; once reconstituted, MOTS-c must remain refrigerated at 2–8°C and never frozen.

Lyophilised MOTS-c should be stored at −20°C in a sealed container with desiccant to prevent moisture absorption, where it remains stable for 24–36 months. The freeze-dried powder lacks the water required for hydrolytic degradation, and freezer storage suppresses residual oxidative reactions. Refrigeration at 2–8°C is acceptable for short-term storage under 6 months but suboptimal for extended preservation — the lower temperature provides additional protection against thermal and oxidative degradation pathways.

A 24-hour exposure to 20–25°C causes approximately 22–28% peptide degradation in reconstituted MOTS-c as measured by HPLC, representing irreversible peptide bond cleavage that refrigeration cannot reverse. This degradation is cumulative — a solution experiencing multiple short ambient exposures accumulates damage with each event. At room temperature, the half-life of reconstituted MOTS-c is approximately 24–36 hours, meaning 50% of the peptide will have degraded within that timeframe.

MOTS-c, BPC-157, and Ipamorelin all require refrigeration at 2–8°C once reconstituted, but their degradation kinetics differ based on amino acid composition and sequence length. MOTS-c is a 16-amino-acid mitochondrial peptide with specific sensitivity to hydrolysis at positions 8–12; [BPC-157](https://www.realpeptides.co/products/bpc-157-peptide/) is a 15-amino-acid gastric peptide with pentadecapeptide stability; [Ipamorelin](https://www.realpeptides.co/products/ipamorelin/) is a pentapeptide growth hormone secretagogue with shorter chain length conferring slightly higher thermal stability. All share the fundamental requirement for cold chain storage, and all degrade irreversibly at ambient temperature.

MOTS-c reconstituted 30 days prior falls outside the validated 28-day stability window and should be discarded regardless of continuous refrigeration. Peptide bond hydrolysis proceeds even under refrigeration — it is suppressed but not halted. After 28 days at 2–8°C, purity typically drops below 90%, and the degradation products (fragmented amino acid chains) can interfere with AMPK receptor binding assays. For research-grade work requiring reproducible results, adhere strictly to the 28-day discard protocol.

Visual inspection cannot reliably detect peptide degradation — degraded MOTS-c appears clear and unchanged even after complete peptide fragmentation. The only definitive method is HPLC analysis comparing the current sample to a reference standard, which quantifies peptide purity and identifies degradation products. If HPLC is unavailable and a temperature breach occurred, assume degradation proportional to the breach duration and temperature, and either discard the vial or document the incident and monitor for attenuated research outcomes.

Yes, reconstituted MOTS-c can be stored alongside other peptides such as [Sermorelin](https://www.realpeptides.co/products/sermorelin/), [Tesamorelin](https://www.realpeptides.co/products/tesamorelin-peptide/), or [NAD+](https://www.realpeptides.co/products/nad-100mg/) in the same refrigerator provided each vial is sealed, labelled with reconstitution date, and stored upright to prevent cross-contamination. Avoid storing peptides in refrigerator doors where temperature fluctuates with frequent opening — place vials in the main compartment toward the back where temperature remains most stable.

Inspect the vial for discolouration and immediately transfer to −20°C storage. Lyophilised peptides tolerate brief ambient exposure during shipping far better than reconstituted solutions — a 48–72 hour period at 20–25°C typically causes under 5% degradation in anhydrous powder. If the powder appears yellow, brown, or clumped rather than white to off-white, contact the supplier for replacement. Real Peptides guarantees cold chain integrity and provides temperature breach replacement for any shipment showing excursion beyond specification.

MOTS-c degradation accelerates at higher temperatures because heat provides the activation energy required for peptide bond hydrolysis, the nucleophilic attack by water molecules on amide linkages holding the amino acid chain together. Every 10°C increase in temperature approximately doubles the reaction rate following the Arrhenius equation — this is why MOTS-c at 30°C degrades four times faster than at 10°C. Refrigeration at 2–8°C suppresses molecular kinetic energy, reducing collision frequency between water molecules and peptide bonds, thereby extending the half-life from 24–36 hours at room temperature to 21–28 days under cold storage.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA